Generation of a diverse and self-tolerant T-cell repertoire requires appropriate interpretation of T-cell antigen receptor (TCR) signals by CD4 1 CD8 1 double-positive thymocytes. Thymocyte cell fate is dictated by the nature of TCR-major-histocompatibility-complex (MHC)-peptide interactions, with signals of higher strength leading to death (negative selection) and signals of intermediate strength leading to differentiation (positive selection) 1 . Molecules that regulate T-cell development by modulating TCR signal strength have been described but components that specifically define the boundaries between positive and negative selection remain unknown. Here we show in mice that repression of TCR-induced death pathways is critical for proper interpretation of positive selecting signals in vivo, and identify schnurri-2 (Shn2; also known as Hivep2) as a crucial death dampener. Our results indicate that Shn2 2/2 double-positive thymocytes inappropriately undergo negative selection in response to positive selecting signals, thus leading to disrupted T-cell development. Shn2 2/2 double-positive thymocytes are more sensitive to TCR-induced death in vitro and die in response to positive selection interactions in vivo. However, Shn2-deficient thymocytes can be positively selected when TCR-induced death is genetically ablated. Shn2 levels increase after TCR stimulation, indicating that integration of multiple TCR-MHC-peptide interactions may fine-tune the death threshold. Mechanistically, Shn2 functions downstream of TCR proximal signalling compenents to dampen Bax activation and the mitochondrial death pathway. Our findings uncover a critical regulator of T-cell development that controls the balance between death and differentiation.
Cell intrinsic defects in the generation of T cells generally map to either TCR proximal signalling molecules or to two major pathways: the calcineurin/NFAT and Raf/Mek/Erk pathways [2] [3] [4] [5] . Shn family proteins are large zinc-finger-containing proteins that regulate morphogenesis in Caenorhabditis elegans and Drosophila 6,7 . In vertebrates, they influence bone formation, adipogenesis and memory T-cell survival [8] [9] [10] . Interestingly, Shn2 2/2 mice have very few post-selection doublepositive thymocytes or mature single-positive thymocytes but how Shn2 regulates T-cell development has remained a mystery 11 (Fig. 1a ).
We began investigating this severe defect by examining TCR proximal signalling events that are known to be required for, or associated with, positive selection. Shn2 1/1 and Shn2 2/2 double-positive thymocytes similarly upregulated CD69, a canonical activation marker, and had comparable patterns of tyrosine phosphorylated proteins after TCR stimulation, indicating that TCR proximal signalling is unaltered (Supplementary Fig. 1 ). Shn2 2/2 double-positive thymocytes also had equivalent Erk1/2 phosphorylation after TCR activation ( Fig. 1b ). In addition, Shn2 2/2 double-positive thymocytes showed normal NFATc1 dephosphorylation, NFATc1 nuclear localization, and induction of the NFAT target gene Egr2 in response to TCR stimulation, thus indicating that the calcineurin/NFAT pathway is activated normally in these cells ( Fig. 1c and Supplementary Fig. 2 , data not shown).
In further support of this, microarray analysis of CD4 1 CD8 1 CD69 2 thymocytes before and after TCR stimulation yielded very few differences in basal and induced gene expression between Shn2 1/1 and Shn2 2/2 thymocytes (data not shown). A second, independent microarray analysis also did not detect significant changes in gene expression (T.T. and S.I., unpublished observations). To further examine specific transcription factor activity we transfected luciferase reporter constructs into control and Shn2 2/2 primary double-positive thymocytes. NFAT, AP1, NF-kB and Smad activation was comparable between Shn2 1/1 and Shn2 2/2 double-positive thymocytes ( Supplementary Fig. 2 ). Although evidence in other cell types indicates that Shn proteins may influence NF-kB or Smad activity these pathways are not regulated by Shn2 in thymocytes 8, 12 .
On the basis of the unexpected finding that Shn2 does not regulate proximal TCR signalling or positive selection pathways, we examined Shn2 2/2 double-positive cells more generally. Thymocyte death in vivo can result from either negative selection (in response to strong TCR signals) or death by neglect (in response to weak or no signal) 1 . Therefore, we investigated the response of Shn2 2/2 double-positive thymocytes to a gradient of TCR stimulation. Shn2 2/2 double-positive thymocytes were markedly sensitive to death induced by CD3/CD28 ligation, exemplified by a nearly tenfold shift in responsiveness ( Fig. 1d ). In contrast, Shn2 1/1 and Shn2 2/2 double-positive thymocytes died comparably in response to CD3 alone, under in vitro conditions that approximate death by neglect, and in response to the non-TCR death signals dexamethasone, Fas, or TNF-a treatment (Fig. 1e , f and Supplementary Fig. 3 ). Thus, although Shn2 2/2 double-positive thymocytes respond normally to non-TCR death signals, they appear to be hyper-responsive to TCR/costimulationinduced cell death. Shn2 2/2 double-positive thymocytes showed increased levels of early death markers, namely caspase activation and disruption of mitochondrial membrane potential, as well as increased upregulation of the late death marker annexin V in response to CD3/CD28 stimulation ( Fig. 1d , g). Collectively, these data indicate that Shn2 2/2 double-positive thymocytes do not have an inherent survival defect, but rather have an altered perception of TCR signal strength that leads to inappropriate apoptosis via the intrinsic death pathway.
Because TCR-induced death is specifically affected in Shn2 2/2 double-positive thymocytes, we examined components upstream of the mitochondria in the intrinsic death pathway to map the stage at which Shn2 functions. In thymocytes, TCR signalling can induce Bim and ultimately lead to conversion of Bax to an active conformation, disruption of the mitochondrial membrane, and apoptosis [13] [14] [15] . Using a conformation-specific antibody we found increased Bax activation in Shn2 2/2 double-positive thymocytes after TCR stimulation, indicating that increased cell death in Shn2 2/2 double-positive thymocytes is mediated by this pro-apoptotic protein 16 (Fig. 1h and Supplementary Fig. 4 ).
Our findings indicating that Shn2 deficiency alters the threshold of TCR-mediated cell death led us to consider a role for Shn2 in the balance of positive and negative selection. Strong negative selecting signals activate both the differentiation pathway and the death pathway; however, because the death pathway acts in a dominant manner, negative selecting signals result in apoptosis rather than differentiation 2 . In contrast, signals of intermediate strength are able to induce differentiation and positive selection without triggering activation of the intrinsic cell death pathway. It remains unclear how positive selection prevails in response to signals of intermediate strength. We proposed that Shn2 acts to dampen death induced by TCR signalling, thereby allowing positive selection to proceed in response to signals of intermediate strength. In this scenario, Shn2 2/2 thymocytes inappropriately activate death pathways in response to positive selection signals ( Supplementary Fig. 12 ). Therefore, we asked whether preventing Shn2 2/2 thymocytes from dying would allow them to complete positive selection and mature into CD4 and CD8 single-positive cells. The pro-apoptotic protein Bim is a key component of TCR-induced death in thymocytes 17 . We therefore used the Bim 2/2 genetic background as a tool to eliminate TCR-induced death. Genetic inhibition of negative selection by Bim deficiency rescued differentiation of Shn2 2/2 thymocytes, as evidenced by the presence of mature single-positive cells in the thymus and mature T cells in the periphery (Fig. 2a, b Shn2
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Anti-CD3 (μg ml -1 ) +5 x anti-CD28 Supplementary Fig. 5 ). These data reinforced the conclusion that differentiation pathways are functional in Shn2-deficient cells, which can mature when death pathways are eliminated. Next we closely analysed the consequence of positive selection interactions in vivo in the presence or absence of Shn2. Our in vitro data indicate that in the absence of Shn2 there could be increased death in response to positive selection interactions. However, Shn2 1/1 and Shn2 2/2 mice with polyclonal TCR repertoires have similar total thymocyte numbers and an equally low percentage of dying thymocytes. This may result from the fact that in a diverse, polyclonal repertoire only a small fraction of double-positive thymocytes are undergoing a positive selection at any snapshot in time (Fig. 3b ). On the other hand, the majority of double-positive thymocytes in TCR transgenic mice express a TCR of defined specificity; in this system, the effect of positive and negative selecting signals can be dissected and analysed separately. To examine the role of Shn2 in the interpretation of TCR signals in response to positive selection interactions in vivo, we crossed Shn2 2/2 mice to three different TCR transgenic strains: DO11, AND and HY. Shn2 2/2 DO11 mice had markedly reduced total and double-positive thymocyte numbers and an altered CD4/CD8 staining profile ( Fig. 3a, b) . A change in double-positive:double-negative ratio can be indicative of either a developmental block at the doublenegative stage or increased double-positive cell death. The decrease in thymocyte number was not due to an early double-negative cell defect, as double-negative cell development was normal in Shn2 2/2 mice ( Supplementary Fig. 6 ). A higher percentage of Shn2 2/2 DO11 thymocytes were annexin V 1 and showed caspase activation indicating that the decrease in thymic cellularity is due to increased cell death. Hence, we conclude that Shn2 actively represses thymocyte death in response to positive selection interactions in vivo (Fig. 3c,  d) . Results from the AND and the HY TCR transgenic models also indicated that in the absence of Shn2 positive selection was converted to death in vivo. Shn2 2/2 AND and Shn2 2/2 HY female mice had reduced thymocyte number and an altered CD4/CD8 staining profile (Fig. 3e, f and Supplementary Fig. 7) . We also used the DO11 TCR transgenic system to more closely investigate the rescued singlepositive cells in Shn2 2/2 Bim 2/2 mice and determine whether cells could be rescued from death in response to positive selection interactions. The appearance of mature single-positive thymocytes and large numbers of mature T cells in the periphery in 
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TCR transgenic mice indicated that Bim deficiency rescued Shn2 2/2 thymocytes receiving positive selection interactions in vivo (Fig. 3g, h and Supplementary Fig. 8 ).
We interrogated negative selecting interactions in vivo in the absence of Shn2. Shn2-deficiency did not alter negative selection in response to the male-specific self antigen in male HY mice or in response to endogenous deleting superantigens in AND mice 18 (Supplementary Fig. 7) . Thus, in the absence of Shn2, physiological negative selection is unaltered.
To determine whether TCR-MHC interactions were required to kill Shn2 2/2 DO11 thymocytes in vivo, bone marrow from Shn2 1/1 DO11 and Shn2 2/2 DO11 mice was transplanted into irradiated MHC I 2/2 II 2/2 and wild-type recipients. Thymocyte numbers in MHC I 2/2 II 2/2 mice reconstituted with Shn2 2/2 DO11 bone marrow were rescued to the level found in MHC I 2/2 II 2/2 chimeras generated with Shn2 1/1 DO11 bone marrow, whereas thymocyte numbers in wild-type mice that received Shn2 2/2 DO11 bone marrow were still low (Fig. 4a, b) . These data, together with the rescue of CD4 singlepositive cells in Shn2 2/2 Bim 2/2 DO11 TCR transgenic mice, point to a role for positively selecting interactions killing Shn2 2/2 thymocytes in vivo. Additionally, naive Shn2 2/2 DO11 double-positive thymocytes that developed in MHC I 2/2 II 2/2 chimaeras were more sensitive to death induced by antigen presenting cells (APCs) loaded with OVA peptide in vitro as evidenced by enhanced death at lower concentrations of peptide (Fig. 4c ). Similar results were obtained when Shn2 2/2 AND double-positive thymocytes were exposed to their cognate antigen in vitro (Fig. 4d) .
Interestingly, Shn2 heterozygous mice have only half the normal number of mature single-positive cells, indicating that thymocyte viability is highly sensitive to Shn gene dosage in vivo 11, 19 (Supplementary Fig. 9 ). Given that thymocytes undergo multiple interactions before being relegated to death or differentiation 20,21 , we investigated whether Shn2 expression levels are static or dynamic during thymocyte development. TCR stimulation or pharmacological activation increases Shn2 expression by double-positive thymocytes (Fig. 4e-g) . Although cyclosporin A (CsA) treatment has a small effect on Shn2 induction, Ca 21 / calmodulin blockade completely inhibits Shn2 induction, indicating that another calmodulin-dependent pathway regulates TCR-induced Shn2 expression. The dynamic changes in Shn2 levels indicate that fine tuning of the death threshold may rely on the integration of previous TCR-MHC interactions and that upregulation of Shn2 expression may serve to adjust death pathway thresholds and allow positive selection of appropriate cells.
During T-cell development the proper interpretation of TCR signals is the critical event that induces the differentiation of productive cells and the elimination of potentially destructive ones. There is a clearly defined border between positive and negative selection that is dependent on the affinity of TCR-MHC interactions 22 . Where and how the signals activating positive and negative selection pathways diverge remains unknown. Here we show that Shn2 is critical in maintaining 
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the balance between death and differentiation by repressing TCRinduced death pathways. Investigation of events upstream of Bax activation revealed that basal and TCR-induced levels of Bim and Nur77, two critical regulators of TCR-induced cell death during negative selection 17, 23 , were unperturbed in the absence of Shn2 (Supplementary Fig. 10 ). In addition, phosporylation of Bim, critical for cell death in vivo, was unaltered in Shn2 2/2 double-positive thymocytes 24 ( Supplementary Fig. 4 ). Total protein levels of other apoptotic regulatory molecules (Bcl2, Bcl-XL (also known as Bcl2l1), Mcl1 and Bax) were also normal ( Supplementary Fig. 10 ). These data indicated that Shn2 does not simply regulate the balance between established pro-death and anti-death molecules. Considerable effort has focused on uncovering the intricate mechanism of action by which death proteins regulate cell death in many cell types 25 . Shn2 may control activity of these molecules by regulating their associations with one another or affecting other post-translational modifications. Understanding the exact biochemical mechanism by which Shn2 regulates Bax activation may reveal how the intrinsic death pathway is regulated. Interestingly, whereas some mature thymocytes do develop in Shn2 2/2 mice there is a complete absence of T cells in Shn2 2/2 Shn3 2/2 mice, indicating a functional redundancy among Shn family members ( Supplementary Fig. 11 ). On the basis of the studies described here, we propose a new model in which the previously enigmatic Shn family of proteins functions to oppose activation of negative selection pathways downstream of TCR-MHC interactions of intermediate strength. In this model, Shn-mediated dampening of the intrinsic death pathway is a requisite component to allow the differentiation of mature T cells.
METHODS SUMMARY
Cell isolation and flow cytometry. Double-positive thymocytes were isolated by positive selection of total thymocytes with anti-CD8a magnetic beads (Miltenyi Biotech) with purity greater than 90%. Antibodies used for flow cytometry were from BD Pharmingen and BioLegend. Death was analysed with FAM Poly Caspases Assay Kit (Molecular Probes) and annexin V and JC-1 Mitoscreen Kits (BD Pharmingen) according to the manufacturer's protocol. Cell stimulation. For plate-bound CD3/28 stimulation, plates were coated overnight with indicated concentrations of antibodies. In vitro death assays were performed in triplicate in 96-well flat-bottom plates with 10 5 cells per well for 20 h. Percentage live double-positive was determined by annexin V staining and normalized to unstimulated values. Antigen specific stimulation: 5 3 10 5 double-positive thymocytes were co-cultured with 5 3 10 4 APCs (M12.4.1 cells 26 for DO11 TCR transgenic strains and PI39 cells 27 for AND TCR transgenic strains) and indicated concentrations of OVA 323-339 peptide (GenScript) or PCC 88-104 peptide (Anaspec) for 20 h. Percentage live double-positive was determined by annexin V staining and normalized to values of M12 or P139 cells alone. For RNA and protein analyses, 0.5-1 3 10 7 cells were stimulated in 6-well plates. For inhibitor studies, cells were stimulated with PMA (5 nM), ionomycin (1 mM), or platebound anti-CD3 (10 mg ml 21 )/anti-CD28 (50 mg ml 21 ). Cells were pretreated with inhibitors for 30 min: BAPTA-AM (20 mM), CsA (200 ng ml 21 ), W7 (100 mM), KN62 (10 mM), STO69 (10 mg ml 21 ), BIM1 (1 mM), Go6976 (1 mM), UO126 (10 mM) and SP600125 (10 mM). Bax immunoprecipitation. Cells (2 3 10 7 ) were stimulated with PMA (5 nM) and ionomycin (1 mM) for 4 h, washed once with PBS, and resuspended in lysis buffer (10 mM HEPES, 150 mM NaCl) containing either 0.2% NP-40 or 1% CHAPs plus protease and phosphatase inhibitors. Active conformation Bax antibody (6A7, eBioscience) was used to immunoprecipitate overnight. Membranes were blotted with rabbit polyclonal Bax antibody (Millipore).
